iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Fortis Healthcare Q3 net profit declines 5.6% to ₹134 Crore

8 Feb 2024 , 10:27 AM

On February 7, Fortis Healthcare Ltd reported a 5.6% year-on-year (YoY) decline in net profit to ₹134 Crore for the October-December quarter of the current fiscal year.

Fortis posted a net profit of ₹142 Crore a year earlier.

The hospital operator recorded consolidated revenue of ₹1,680 Crore, a 7.70% increase from ₹1,560 Crore in the previous year.

Its profits before interest, taxes, depreciation, and amortisation (EBITDA) were ₹284 Crore, up from ₹276 Crore in the same period last year, according to a corporate statement.

The EBITDA margin was 16.90%, down from 17.70% in the same quarter a year earlier.

Occupancy stood at 64%, down from 66.10% in the third quarter of fiscal year 23. The average revenue per operating bed (ARPOB) increased by 10.60% to ₹2.23 Crore in Q3FY24 from ₹2.02 Crore in the previous year.

In November, Fortis Healthcare announced that it has inked formal agreements to sell Fortis Malar Hospital in Chennai to MGM Healthcare Private Limited for about ₹128 Crore.

The business built a 70-bed state-of-the-art facility in Ludhiana. This is Ludhiana’s second facility, and the fourth in Punjab. The business expects to expand brownfield beds by around 2,200 beds over the next four years, according to an exchange filing.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • Fortis Healthcare
  • Fortis Healthcare news
  • Fortis Healthcare Q3
  • Fortis Healthcare Updates
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.